NeuroPace

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: 167

Market Cap: -

Website

Introduction: NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.

Clinical Trials

RNS System LGS Feasibility Study

Phase 2

Active, not recruiting

Conditions: Seizures
Seizures, Generalized
Epilepsy
Lennox-Gastaut Syndrome, Intractable
Lennox Gastaut Syndrome

Interventions: Device: RNS System

First Posted Date: 2022-04-21

Last Posted Date: 2024-11-27

Lead Sponsor: NeuroPace

Target Recruit Count: 22

Registration Number: NCT05339126

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 3 locations

RNS System NAUTILUS Study

Phase 3

Active, not recruiting

Conditions: Epilepsy
Idiopathic Generalized Epilepsy
Generalized Tonic Clonic Seizure

Interventions: Device: Responsive stimulation
Device: Sham stimulation

First Posted Date: 2021-12-07

Last Posted Date: 2024-12-11

Lead Sponsor: NeuroPace

Target Recruit Count: 100

Registration Number: NCT05147571

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Mayo Clinic - Arizona, Phoenix, Arizona, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States

and more 20 locations

RNS System RESPONSE Study

Not Applicable

Terminated

Conditions: Drug Resistant Epilepsy
Epilepsy
Focal Epilepsy
Neurostimulator; Complications
Partial Seizure

Interventions: Device: RNS System

First Posted Date: 2021-04-09

Last Posted Date: 2025-05-22

Lead Sponsor: NeuroPace

Target Recruit Count: 9

Registration Number: NCT04839601

Locations: 🇺🇸
Spectrum Health System, Grand Rapids, Michigan, United States
🇺🇸
Westchester Medical Center, Hawthorne, New York, United States

RNS® System Epilepsy Post-Approval Study

Active, not recruiting

Conditions: Epilepsy

Interventions: Device: RNS System

First Posted Date: 2015-03-31

Last Posted Date: 2025-05-22

Lead Sponsor: NeuroPace

Target Recruit Count: 375

Registration Number: NCT02403843

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Stanford University, Palo Alto, California, United States

and more 32 locations

RNS® System LTT Study

Phase 4

Completed

Conditions: Epilepsy

Interventions: Device: RNS® System

First Posted Date: 2007-12-12

Last Posted Date: 2019-06-26

Lead Sponsor: NeuroPace

Target Recruit Count: 230

Registration Number: NCT00572195

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Saint Barnabas Medical Center, Livingston, New Jersey, United States
🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

and more 30 locations

RNS® System Pivotal Study

Phase 3

Completed

Conditions: Epilepsy

Interventions: Procedure: RNS® System implantation
Device: RNS® System responsive stimulation

First Posted Date: 2005-12-13

Last Posted Date: 2013-08-28

Lead Sponsor: NeuroPace

Target Recruit Count: 240

Registration Number: NCT00264810

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸
Via Christi Comprehensive Epilepsy Center, Wichita, Kansas, United States

and more 29 locations

Study of an External Responsive Neurostimulator System on Epileptiform Activity

Phase 2

Completed

Conditions: Epilepsy

First Posted Date: 2005-09-12

Last Posted Date: 2010-08-26

Lead Sponsor: NeuroPace

Target Recruit Count: 150

Registration Number: NCT00158067

Locations: 🇺🇸
Research Site, New York, New York, United States

RNS® System Feasibility Study

Phase 2

Completed

Conditions: Epilepsy

Interventions: Procedure: RNS® System implantation
Device: RNS® System responsive stimulation

First Posted Date: 2004-03-16

Last Posted Date: 2014-01-29

Lead Sponsor: NeuroPace

Target Recruit Count: 70

Registration Number: NCT00079781

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸
Swedish Medical Center, Seattle, Washington, United States
🇺🇸
Rush University Medical Center / Epilepsy Center, Chicago, Illinois, United States

and more 9 locations

Home Terms & Conditions Privacy Policy